Stage IIIA Colorectal Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Pemigatinib (DB15102)

IndicationStatusPhase
DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04096417Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR AlterationsTreatment